Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic

  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biocryst Pharma Inc (NQ: BCRX )

7.600 +0.110 (+1.47%)
Streaming Delayed Price Updated: 11:58 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biocryst Pharma Inc

< Previous 1 2 3 4 5 6 7 Next >
BioCryst Pharmaceuticals (BCRX) Q2 2023 Earnings Call Transcript
BCRX earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2023
Via Benzinga
Analyst Expectations for BioCryst Pharma's Future
Via Benzinga
BioCryst Pharmaceuticals (BCRX) Q1 2023 Earnings Call Transcript
BCRX earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Why BioCryst Pharmaceuticals Stock Is Soaring Today
The biotech's Q1 earnings report contained a number of positives. 
Via The Motley Fool
BioCryst Clocks 37.8% Revenue Growth In Q1 On Solid New Patient Growth
Via Benzinga
Recap: BioCryst Pharma Q1 Earnings
Via Benzinga
Why Shares of BioCryst Pharmaceuticals Jumped Today
A day after the stock plummeted, it bounced back. 
Via The Motley Fool
Why Is BioCryst Pharmaceuticals (BCRX) Stock Down 8% Today?
BioCryst Pharmaceuticals (BCRX) stock is slipping on Tuesday after the biotech company announced new funding to pay down debts. 
Via InvestorPlace
Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Analyst Sees Attractive Entry Opportunity After BioCryst's Pipeline Setback
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
Via Benzinga
Why BioCryst Pharmaceuticals Stock Is Sinking Today
Investors didn't like the drugmaker's Q4 update. 
Via The Motley Fool
Biocryst Pharmaceuticals's Earnings Outlook
Via Benzinga
BioCryst Shelves Development Of Rare Blood Disorder Candidate
Via Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023. 
Via Benzinga
BioCryst Pharmaceuticals (BCRX) Q4 2022 Earnings Call Transcript
BCRX earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Why BioCryst Pharmaceuticals Stock Is Sliding Today
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading lower Tuesday after the company reported worse-than-expected earnings results< 
Via Benzinga
Expert Ratings for BioCryst Pharmaceuticals
Analysts have provided the following ratings for BioCryst Pharmaceuticals (NASDAQ:BCRX) within the last quarter: 
Via Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash. 
Via Benzinga
BioCryst Pharmaceuticals Stock Is Tumbling: What's Going On?
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading lower Monday after the company announced preliminary fourth-quarter and full 
Via Benzinga
TSLA Stock Price Prediction: What to Know as Analysts Slash Tesla Price Targets
Tesla (TSLA) stock is in the news as price predictions continue to be a hot topic among traders after Elon Musk's Twitter purchase. 
Via InvestorPlace
Why Is Getaround (GETR) Stock Up 6% Today?
Getaround (GETR) stock is on the move Thursday with heavy trading despite a lack of recent news concerning the car-sharing service. 
Via InvestorPlace
BCRX Stock Sinks as BioCryst Discontinues Drug Development
BioCryst Pharmaceuticals (BCRX) stock is falling on Thursday after revealing it's no longer developing BCX9930 for competitive reasons. 
Via InvestorPlace
Novavax, Tesla, Western Digital And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
VF Corp, Verve Therapeutics And Some Other Big Stocks Moving Lower On Monday
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
BioCryst Pharmaceuticals Stock Sees RS Rating Rise To 84
The Relative Strength (RS) Rating for BioCryst Pharmaceuticals stock climbed into a new percentile Friday, with a rise from 64 to 84. 
Via Investor's Business Daily
4 Analysts Have This to Say About BioCryst Pharmaceuticals
Within the last quarter, BioCryst Pharmaceuticals (NASDAQ:BCRX) has observed the following analyst ratings: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
Upgrades 
Via Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.